Biomedical engineers at USC have been awarded a $2.4 million federal grant to study how nanoparticles can treat kidney disease, the university announced Oct. 2.
The National Institutes of Health has conferred its New Innovator Award of $2,433,330 to Eun Ji Chung, an assistant professor of biomedical engineering at the USC Michelson Center for Convergence Bioscience.
Chung will apply the NIH innovation grant – one of only four ever given to USC – to advance research at the junction of biology and nanotechnology.
She aims to study how a nanoparticle can ferry various types of medicine to treat autosomal dominant polycystic kidney disease, an inherited disorder difficult to treat with dialysis or a kidney transplant. The trick: How sneak a targeted drug into a kidney and prevent it from being eliminated by the body.
“Our approach is the first of its kind and represents a paradigm shift from current therapies to treat polycystic kidney disease,” Chung said in a statement.
Chung and others to have received New Innovator Awards will be recognized at an NIH High-Risk, High Reward Research Symposium in June 2019.
Health business reporter Dana Bartholomew can be reached at email@example.com. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Children’s Hospital Los Angeles Receives $1.2 Million to Study Drug Resistance in Leukemia
- Cedars-Sinai Awarded $12 Million to Study Deadly Lung Diseases
- NIH awards Children’s Hospital L.A. $1.7M to Study Preemies
- Children’s Hospital Los Angeles Awarded $1.5 Million Research Grant
- L.A. Bioscience Gets $1 Billion in Federal Research Funds, Study Finds
- USC to Join $1.5 Billion NIH Study on Precision Medicine
- Stem Cell Agency Awards $11 Million to SoCal Researchers to Fight Disease
- CHLA Receives $2.3M to Study Bone Loss Tied to Cerebral Palsy